A key Senate committee is pushing forward with a surprisingly ambitious plan to lower drug prices as well as other health care costs.

The bipartisan pair atop the Senate Health, Education, Labor, and Pensions committee formally introduced a major health care package Tuesday and simultaneously scheduled a vote on the measure for next week. It will be the first time a major Senate committee has taken up drug pricing legislation this year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Bravo Senate !!!!! Govern the PBM’s and stop them from fleecing America and we’ll all see how much money will be saved. The Attorney General’s from 31 states are investigating PBM’s. They all can’t be wrong !!!!!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy